Biju Chorinchath

Biju Chorinchath has a diverse work experience in the pharmaceutical industry. Biju started as a Director at Pfizer Pharmaceuticals in 2001 and held various roles until 2010. Subsequently, they worked at Swedish Orphan Biovitrum International (Sobi) as Head of Marketing - North America and later as Vice President, Head of Strategic Planning/Business Development - North America. Biju then joined CSL Behring in 2015 as Head, US Marketing - Immunology/Neurology Therapeutic Area until 2019. Currently, they are the Head of US Marketing, Market Access, Channel Operations, and Business Development at Almirall since November 2019. Throughout their career, Biju has demonstrated strong leadership and strategic planning skills, contributing to revenue growth and value creation within the companies they have worked for.

Biju Chorinchath earned a Bachelor's degree from Delhi University. Biju then went on to attend Harvard University, where they obtained a Masters in Health Policy and Management between 1995 and 1997.